Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
A review of an emerging enteric pathogen: enteroaggregative Escherichia coli Huang DB; Mohanty A; DuPont HL; Okhuysen PC; Chiang TJ Med Microbiol 2006[Oct]; 55 (Pt 10): 1303-1311Enteroaggregative Escherichia coli (EAEC) is an increasingly recognized enteric pathogen. It is a cause of both acute and persistent diarrhoea among children, adults and HIV-infected persons, in both developing and developed countries. In challenge studies, EAEC has caused diarrhoeal illness with the ingestion of 10(10) c.f.u. Outbreaks of diarrhoeal illness due to EAEC have been reported, and linked to the ingestion of contaminated food. Diarrhoeal illness due to EAEC is the result of a complex pathogen-host interaction. Some infections due to EAEC result in diarrhoeal illness and elicit an inflammatory response, whereas other infections do not result in a symptomatic infection. Many putative virulence genes and EAEC strains that produce biofilm have been identified; however, the clinical significance of these genes and of biofilm production has yet to be defined. A -251 AA single nucleotide polymorphism (SNP) in the interleukin (IL)-8 promoter region is reported to increase host susceptibility to EAEC diarrhoea. Ciprofloxacin and rifaximin continue to be an effective treatment in persons infected with EAEC. This review is intended to provide an updated review for healthcare workers on EAEC, an emerging enteric pathogen.|*Disease Outbreaks[MESH]|Adult[MESH]|Animals[MESH]|Anti-Infective Agents/therapeutic use[MESH]|Antidiarrheals/therapeutic use[MESH]|Bacterial Adhesion[MESH]|Biofilms/growth & development[MESH]|Child[MESH]|Child, Preschool[MESH]|Clinical Trials as Topic[MESH]|DNA, Bacterial/genetics/isolation & purification[MESH]|Diarrhea/complications/drug therapy/*epidemiology/microbiology[MESH]|Escherichia coli Infections/complications/diagnosis/*epidemiology/genetics[MESH]|Escherichia coli/isolation & purification/*pathogenicity/physiology[MESH]|Food Microbiology[MESH]|Genes, Bacterial/physiology[MESH]|Genetic Predisposition to Disease[MESH]|Global Health[MESH]|HIV Infections/complications[MESH]|Humans[MESH]|Interleukin-8/genetics[MESH]|Promoter Regions, Genetic[MESH]|Virulence[MESH]|Virulence Factors/genetics[MESH] |
